title: Improvement of mucocutaneous involvement of immunoglobulin light chain amyloidosis after chemotherapy and hematopoietic stem cell transplantation for multiple myeloma.
authors.affiliation: Department of Dermatology, Department of Medicine, School of Medicine, Keio University, Tokyo, Japan.
authors.forename: Ryoko
authors.initials: R
authors.lastname: Hosokawa
authors.forename: Manabu
authors.initials: M
authors.lastname: Ohyama
authors.forename: Kaori
authors.initials: K
authors.lastname: Murakami
authors.forename: Daichi
authors.initials: D
authors.lastname: Abe
authors.forename: Kenji
authors.initials: K
authors.lastname: Yokoyama
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Okamoto
authors.forename: Masayuki
authors.initials: M
authors.lastname: Amagai
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000209:etiology* / Q000628:therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000150:complications* / Q000628:therapy; D011719:Pyrazines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib